01093.HK
CSPC Pharmaceutical Group Limited
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 9.69
+0.78%Year over year
Reported trailing growth
- Revenue
- -10.3%
- EBITDA
- -7.2%
- EBIT
- -8.8%
- EPS
- -3.8%
- Free cash flow
- +23.2%
- Operating cash flow
- -0.2%
Forward estimates
Based on analyst estimates
- Revenue
- -44.6%
- EBITDA
- -48.1%
- EPS
- -49.5%
Three-year CAGR
- Revenue
- -7.1%
- EBITDA
- -16.0%
- EBIT
- -17.7%
- Net income
- -15.3%
- EPS
- -14.1%
- Free cash flow
- -15.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026